ITI is a program of The Task Force for Global Health.
Cote d’Ivoire was not originally suspected for trachoma. In 2008, the country started mapping areas which shared borders with Guinea, Mali and Burkina Faso, countries endemic for trachoma. Trachoma was found to be endemic in areas of the district of Odienné, however, no action was taken at this time. In 2015 Cote d’Ivoire was able to participate in GTMP, and mapping took place in 10 districts.
The trachoma program in Cote d’Ivoire is housed within the National Program for Eye Health and Onchocerciasis (PNSOLO)
CURRENT IMPLEMENTATION STATUS
2016 was Cote d’Ivoire’s first year of SAFE implementation. MDAs occurred in 4 districts, Touba, Minignan, Odienné and Bouna.
In 2017 the program was able to map an additional 11 districts. Of these 11, 5 were >5% TF.
Funding remains a significant concern for Cote d’Ivoire. The program was not able to scale up as it wished in 2017 due to a lack of funding.
Zithromax® Shipments by Year